To this purpose, we first exposed the mouse insulinoma cell line β-TC3 to chronic treatment with IL-1β + IFN-γ, generating a cytokine-resistant cell line (β-TC3R). The gene discussed is IL1B; the disease is pancreatic insulinoma.